Quarterly Results

  • Company Name :
Sequent Scientific Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 512529
  • NSE Symbol:
  • SEQUENT
  • P/E(TTM):
  • 360.16
  • ISIN Demat:
  • INE807F01027
  • Div & Yield%:
  • 0.00
  • EPS(TTM):
  • 0.62
  • Book Value(₹):
  • 46.71
  • Market Cap(₹Cr.):
  • 5,648.36
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 34.03 41.07 42.33
Excise Duty 0.00 0.00 0.00
Net Sales 34.03 41.07 42.33
Other Operating Income 0.00 0.00 0.00
Other Income 11.75 11.48 12.27
Total Income 45.78 52.55 54.60
Total Expenditure 38.37 44.36 45.40
PBIDT 7.41 8.19 9.20
Interest 0.83 1.08 0.99
PBDT 6.58 7.11 8.21
Depreciation 2.24 2.33 2.30
Tax 2.25 0.84 1.11
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -0.99 0.57 0.57
Reported Profit After Tax 3.08 3.37 4.23
Extra-ordinary Items -0.82 -0.88 -0.18
Adjusted Profit After Extra-ordinary item 3.90 4.25 4.41
EPS (Unit Curr.) 0.12 0.14 0.17
EPS (Adj) (Unit Curr.) 0.12 0.14 0.17
Calculated EPS (Unit Curr.) 0.12 0.13 0.17
Calculated EPS (Adj) (Unit Curr.) 0.12 0.13 0.17
Calculated EPS (Ann.) (Unit Curr.) 0.49 0.54 0.68
Calculated EPS (Adj) (Ann.) (Unit Curr.) 0.49 0.54 0.68
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 50.33 50.07 50.06
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 21.77 19.94 21.73
PBDTM(%) 19.34 17.31 19.40
PATM(%) 9.05 8.21 9.99